# T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
Canonical URL: https://biopharmsignal.com/news/TTOO/t2-biosystems-achieves-key-milestone-with-250-000th-novel-sepsis-test-shipped-globally
Ticker: TTOO
Company: T2 Biosystems
Source: T2 Biosystems
Published: 2024-12-17 14:00 EST
Original Source URL: https://investors.t2biosystems.com
## Summary

Milestone demonstrates the growing customer adoption of the Company’s proprietary technology LEXINGTON, Mass. , Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it

## Article Body
Milestone demonstrates the growing customer adoption of the Company’s proprietary technology LEXINGTON, Mass. , Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it
## Recent Company News
- 2025-01-07 14:00 EST — [T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-preliminary-fourth-quarter-and-full-year-2024-financial-results) — Source: T2 Biosystems
- 2024-12-18 14:00 EST — [T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-sale-of-four-t2dx-instruments-to-existing-european-distributor) — Source: T2 Biosystems
- 2024-12-17 14:00 EST — [T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally](https://biopharmsignal.com/news/TTOO/t2-biosystems-achieves-key-milestone-with-250-000th-novel-sepsis-test-shipped-globally) — Source: T2 Biosystems
- 2024-12-16 14:00 EST — [T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-extension-of-multi-year-capital-equipment-supplier-agreement-with-vizient-inc) — Source: T2 Biosystems
- 2024-12-09 14:00 EST — [T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-plans-to-license-its-proprietary-technology-to-expand-its-leadership-in-direct-from-whole-blood-detection-of-sepsis-causing-pathogens) — Source: T2 Biosystems
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)